Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(27 sites)
France
Hospices Civils de Lyon Hopital Femme Mere Enfant, Bron Hopital Necker Enfants Malades, Paris Hopital Robert Debre, Paris Greece
Agia Sofia Children Hospital, Athens Attikon University General Hospital, Athens General Hospital of Thessaloniki Ippokrateio, Thessaloniki Israel
Meir Medical Center, Kfar Saba Italy
Ospedale Santissima Annunziata, Chieti IRCCS Istituto Giannina Gaslini, Genova Azienda Socio Sanitaria Territoriale Centro Specialistico Ortopedico Traumatologico Gaetano Pini, Milan IRCCS Ospedale Pediatrico Bambino Gesu, Roma Spain
Hospital Universitario Virgen del Rocio, Seville, Andalusia Hospital Universitari Vall d Hebron, Barcelona, Catalonia Hospital Sant Joan de Deu, Esplugues de Llobregat, Catalonia Hospital Universitari i Politecnic La Fe, Valencia, Valencia Hospital Universitario Ramon y Cajal, Madrid Hospital Universitario La Paz, Madrid Switzerland
Centre Hospitalier Universitaire Vaudois, Lausanne Turkey (Türkiye)
Hacettepe Universitesi Tip Fakultesi Hastanesi, Ankara Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi, Istanbul Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul Umraniye Egitim ve Arastirma Hastanesi, Istanbul Dokuz Eylul Universitesi Tip Fakultesi Hastanesi, Izmir Erciyes Universitesi Tip Fakultesi Hastanesi, Kayseri United Kingdom
Birmingham Childrens Hospital, Birmingham Alder Hey Childrens Hospital, Liverpool John Radcliffe Hospital, Oxford